Single-Inhaler Triple Therapy and Health-Related Quality of Life in COPD: The IMPACT Study

INTRODUCTION: The phase 3 InforMing the PAthway of COPD (chronic obstructive pulmonary disease) Treatment (IMPACT) trial, single-inhaler therapy with fluticasone furoate (FF) 100 μg, umeclidinium (UMEC) 62.5 μg, and vilanterol (VI) 25 μg demonstrated a reduction in the rate of moderate or severe exa...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Adv Ther
Main Authors: Tabberer, Maggie, Jones, C. Elaine, Kilbride, Sally, Halpin, David M. G., Lomas, David A., Pascoe, Steven, Singh, Dave, Wise, Robert A., Criner, Gerard J., Lange, Peter, Dransfield, Mark T., Han, MeiLan K., Martinez, Fernando J., Kaisermann, Morrys C., Lipson, David A.
Format: Artigo
Sprog:Inglês
Udgivet: Springer Healthcare 2020
Fag:
Original Research
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7444357/
https://ncbi.nlm.nih.gov/pubmed/32647911
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12325-020-01409-8
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker